Supplemental Condensed Consolidating Financial Information (Schedule of Condensed Consolidating Statement of Cash Flows) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 1,137	$ 921	$ 1,615
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(123)	(57)	(3,091)
Purchases of property and equipment	(744)	(953)	(853)
Proceeds from disposition of hospitals and other ancillary operations	143	155	88
Proceeds from sale of property and equipment	15	15	50
Purchases of available-for-sale securities	(505)	(162)	(263)
Proceeds from sales of available-for-sale securities	464	156	229
Proceeds from sale of investments in unconsolidated affiliates	403
Distribution from Quorum Health Corporation	1,219
Increase in other investments	(242)	(205)	(511)
Net cash provided by (used in) investing activities	630	(1,051)	(4,351)
Cash flows from financing activities:
Proceeds from exercise of stock options		25	65
Repurchase of restricted stock shares for payroll tax withholding requirements	(6)	(20)	(11)
Stock buy-back		(159)	(9)
Deferred financing costs and other debt-related costs	(26)	(30)	(276)
Proceeds from noncontrolling investors in joint ventures		47	10
Redemption of noncontrolling investments in joint ventures	(19)	(36)	(158)
Distributions to noncontrolling investors in joint ventures	(92)	(100)	(104)
Proceeds from sale-lease back	159
Borrowings under credit agreements	4,879	4,922	9,131
Issuance of long-term debt			4,000
Proceeds from receivables facility	107	206	204
Repayments of long-term indebtedness	(6,715)	(5,050)	(9,980)
Net cash (used in) provided by financing activities	(1,713)	(195)	2,872
Net change in cash and cash equivalents	54	(325)	136
Cash and cash equivalents at beginning of period	184	509	373
Cash and cash equivalents at end of period	238	184	509
Parent Company [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	14	(25)	176
Cash flows from financing activities:
Proceeds from exercise of stock options		25	65
Repurchase of restricted stock shares for payroll tax withholding requirements	(6)	(20)	(11)
Stock buy-back		(159)	(9)
Changes in intercompany balances with affiliates, net	(8)	179	(221)
Net cash (used in) provided by financing activities	(14)	25	(176)
Issuer [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(335)	159	319
Cash flows from investing activities:
Distribution from Quorum Health Corporation	1,219
Net cash provided by (used in) investing activities	1,219
Cash flows from financing activities:
Deferred financing costs and other debt-related costs	(26)	(30)	(276)
Changes in intercompany balances with affiliates, net	801	(181)	(3,334)
Borrowings under credit agreements	4,848	4,880	9,081
Issuance of long-term debt			4,000
Repayments of long-term indebtedness	(6,507)	(4,828)	(9,790)
Net cash (used in) provided by financing activities	(884)	(159)	(319)
Other Guarantor [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	1,322	569	919
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(3)	(21)	(2,876)
Purchases of property and equipment	(519)	(660)	(577)
Proceeds from disposition of hospitals and other ancillary operations	16	21	3
Proceeds from sale of property and equipment	8	7	41
Purchases of available-for-sale securities	(263)	(53)	(23)
Proceeds from sales of available-for-sale securities	218	46	24
Proceeds from sale of investments in unconsolidated affiliates	403
Increase in other investments	(178)	(156)	(352)
Net cash provided by (used in) investing activities	(318)	(816)	(3,760)
Cash flows from financing activities:
Proceeds from sale-lease back	147
Changes in intercompany balances with affiliates, net	(980)	(57)	3,017
Borrowings under credit agreements	28	34	34
Repayments of long-term indebtedness	(68)	(69)	(89)
Net cash (used in) provided by financing activities	(873)	(92)	2,962
Net change in cash and cash equivalents	131	(339)	121
Cash and cash equivalents at beginning of period	31	370	249
Cash and cash equivalents at end of period	162	31	370
Non-Guarantor Subsidiaries [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	136	218	201
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(120)	(36)	(215)
Purchases of property and equipment	(225)	(293)	(276)
Proceeds from disposition of hospitals and other ancillary operations	127	134	85
Proceeds from sale of property and equipment	7	8	9
Purchases of available-for-sale securities	(242)	(109)	(240)
Proceeds from sales of available-for-sale securities	246	110	205
Increase in other investments	(64)	(49)	(159)
Net cash provided by (used in) investing activities	(271)	(235)	(591)
Cash flows from financing activities:
Proceeds from noncontrolling investors in joint ventures		47	10
Redemption of noncontrolling investments in joint ventures	(19)	(36)	(158)
Distributions to noncontrolling investors in joint ventures	(92)	(100)	(104)
Proceeds from sale-lease back	12
Changes in intercompany balances with affiliates, net	187	59	538
Borrowings under credit agreements	3	8	16
Proceeds from receivables facility	107	206	204
Repayments of long-term indebtedness	(140)	(153)	(101)
Net cash (used in) provided by financing activities	58	31	405
Net change in cash and cash equivalents	(77)	14	15
Cash and cash equivalents at beginning of period	153	139	124
Cash and cash equivalents at end of period	$ 76	$ 153	$ 139